Experimental vaccine aims to train immune system to fight HPV cancers
NCT ID NCT06319963
Summary
This early-stage trial is testing a new therapeutic vaccine called Lenti-HPV-07 in people with HPV-related throat or cervical cancer. The main goals are to see if the vaccine is safe and if it can trigger the body's immune system to fight the cancer. The study will enroll 72 participants, who will be followed for up to one year after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Florida Cancer Specialists (from Sarah Canon research Institute)
RECRUITINGOrlando, Florida, 32827, United States
Contact
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact
-
Oklahoma Cancer Specialists and Research Institute, LLC
RECRUITINGTulsa, Oklahoma, 74146, United States
Contact
-
Tampa General Hospital
RECRUITINGTampa, Florida, 33606, United States
Contact
Conditions
Explore the condition pages connected to this study.